The revenue stands at ₹702.70 crore, reflecting a quarter-on-quarter *(QoQ) increase of 6.50 per cent from ₹659.80 crore. This corresponds to a year-on-year *(YoY) growth of 16.61 per cent.
Operating Profit stands at ₹186.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 25.20 per cent from ₹149.20 crore. This corresponds to a year-on-year *(YoY) growth of 10.53 per cent.
PBDT stands at ₹204.70 crore, reflecting a quarter-on-quarter *(QoQ) increase of 23.02 per cent from ₹166.40 crore. This corresponds to a year-on-year *(YoY) growth of 7.85 per cent.
Profit Before Tax stands at ₹160.10 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.80 per cent from ₹124.30 crore. This corresponds to a year-on-year *(YoY) growth of 4.37 per cent.
Net Profit stands at ₹132.20 crore, reflecting a quarter-on-quarter *(QoQ) increase of 44.64 per cent from ₹91.40 crore. This represents a 14.98 per cent year-on-year *(YoY) decline for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dr Lal Pathlabs | 0.22% | 1.68% | 10.84% | 12.00% | 1.04% | 13.51% |
| Narayana Hrudaya | -0.20% | -1.39% | 2.17% | -0.02% | 4.72% | 3.26% |
| Global Health | 0.92% | -0.86% | 10.67% | 5.15% | 2.42% | -3.04% |
| Krishna Institu. | 3.72% | 10.06% | 16.90% | 13.69% | 17.08% | 21.60% |
| Syngene Intl. | -2.51% | -0.93% | 12.53% | 6.91% | -28.91% | -27.43% |
| Poly Medicure | -4.03% | -3.20% | 10.41% | 24.93% | -16.32% | -30.85% |
| Dr Agarwal's Hea | -1.02% | -0.45% | 0.64% | -1.00% | -14.19% | 16.45% |
Chairman cum Managing Director : Arvind Lal
Whole-time Director : Vandana Lal
Whole Time Director & CEO : Om Prakash Manchanda
Director : Rahul Sharma
Independent Director : Arun Duggal
Independent Director : Anoop Mahendra Singh
Independent Director : Sunil Varma
Independent Director : Harneet Singh Chandhoke
Independent Director : Saurabh Srivastava
Company Secretary : Rajat Kalra